Insider · CIK 0001818144
Zubaid Ahmad
Files at SEE (SEALED AIR CORP/DE). First filing -, latest -.
In brief
Zubaid Ahmad files SEC Form 4 as director at SEE (SEALED AIR CORP/DE). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Zubaid Ahmad has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | SEE SEALED AIR CORP/DE | DDisposition to issuer Common Stock | -1,200 | - | - | 0 | Apr 9, 2026 |
| Apr 9, 2026 | SEE SEALED AIR CORP/DE | DDisposition to issuer Stock Unitderivative | -31,608 | - | - | 0 | Apr 9, 2026 |
| May 29, 2025 | SEE SEALED AIR CORP/DE | AGrant or award Stock Unitsderivative | +4,933 | - | - | 30,927 | Jun 4, 2025 |
| May 29, 2025 | SEE SEALED AIR CORP/DE | AGrant or award Stock Unitsderivative | +8,324 | - | - | 34,318 | Jun 2, 2025 |
| May 23, 2024 | SEE SEALED AIR CORP/DE | AGrant or award Stock Unitsderivative | +7,220 | - | - | 25,379 | May 28, 2024 |
Questions about Zubaid Ahmad
Answered from the filings on this page, as of the latest one.
Is Zubaid Ahmad buying or selling?
Zubaid Ahmad has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Zubaid Ahmad's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Zubaid Ahmad has 0.
Where does Zubaid Ahmad file Form 4?
Zubaid Ahmad has filed Form 4 at SEE (SEALED AIR CORP/DE). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.